Effects of Food and Drug Administration-approved medications for Alzheimer’s disease on clinical progression

✍ Scribed by Michelle M. Mielke; Jeannie-Marie Leoutsakos; Chris D. Corcoran; Robert C. Green; Maria C. Norton; Kathleen A. Welsh-Bohmer; JoAnn T. Tschanz; Constantine G. Lyketsos

• Book ID: 118466825
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 206 KB
• Volume: 8
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2011.02.011